4 "Nonalcoholic Steatohepatitis" clinical trials found.
-
A Randomized Double-Blind Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide versus Placebo in Patients with Nonalcoholic Steatohepatitis (NASH)
This study will examen whether the investigational drug, tirzepatide, is safe and able to help study participants with nonalcoholic steatohepatitis (NASH). “Investigational” means that the ...Phase
Interventional
-
Evaluation of Efficacy Safety and Tolerability of NGM282 (Aldafermin) in a Phase 2b Randomized Double-blind Placebo-controlled Multi-center Study in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (ALPINE 4)
The purpose of the study is to examine the effectiveness of aldafermin for the treatment of cirrhosis caused by nonalcoholic steatohepatitis (NASH). The study will ...Phase
Interventional
-
A Phase 2b Randomized Double Blind Placebo-Controlled Multicenter Study Evaluating Safety and Efficacy of EDP-305 in Subjects with Liver Biopsy Proven Non- Alcoholic Steatohepatitis (NASH) (ARGON-2)
The purpose of this study is to compare the effects of the EDP-305 with placebo to see which treatment is better or is safer than ...Phase
Interventional
-
A Study to Evaluate the Degree of Steatosis in Subjects with any Feature of the Metabolic Syndrome in Primary Care or Endocrine Clinics for Non-Alcoholic Fatty Liver Disease (NAFLD) Utilizing Vibration Controlled Transient Elastography (VCTE) and Controll
The purpose of this study is to find out if any of the volunteers have Non-Alcoholic Fatty Liver Disease (NAFLD) which can be diagnosed through ...
